A DNA Vaccine Encoding the VAA Gene of Vibrio anguillarum Induces a Protective Immune Response in Flounder

J Xing, H Xu, X Tang, X Sheng, W Zhan - Frontiers in Immunology, 2019 - frontiersin.org
Vibrio anguillarum is a pathogenic bacterium that infects flounder resulting in significant
losses in the aquaculture industry. The VAA protein previously identified in flounder is …

[HTML][HTML] Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight

C He, M Qin, X Sun - Acta Pharmaceutica Sinica B, 2020 - Elsevier
Coronaviruses (CoVs) are a large family of viruses that cause illness ranging from the
common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS) …

Immunogenicity of high-dose MVA-based MERS vaccine candidate in mice and camels

NK Alharbi, F Aljamaan, HA Aljami, MW Alenazi… - Vaccines, 2022 - mdpi.com
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic pathogen that
can transmit from dromedary camels to humans, causing severe pneumonia, with a 35 …

Characterization of the immune response of MERS-CoV vaccine candidates derived from two different vectors in mice

E Li, F Yan, P Huang, H Chi, S Xu, G Li, C Liu, N Feng… - Viruses, 2020 - mdpi.com
Middle East respiratory syndrome (MERS) is an acute, high-mortality-rate, severe infectious
disease caused by an emerging MERS coronavirus (MERS-CoV) that causes severe …

Combination of biodata mining and computational modelling in identification and characterization of ORF1ab polyprotein of SARS-CoV-2 isolated from …

R Zolfaghari Emameh, H Nosrati, RA Taheri - Biological procedures …, 2020 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is an emerging zoonotic viral
infection, which was started in Wuhan, China, in December 2019 and transmitted to other …

Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus

JN Maslow - Human Vaccines & Immunotherapeutics, 2017 - Taylor & Francis
The past decade and a half has been characterized by numerous emerging infectious
diseases. With each new threat, there has been a call for rapid vaccine development …

Development and validation of different indirect ELISAs for MERS-CoV serological testing

AM Hashem, SS Al-Amri, TL Al-Subhi, LA Siddiq… - Journal of …, 2019 - Elsevier
Since 2012, MERS-CoV has caused up to 2220 cases and 790 deaths in 27 countries with
Saudi Arabia being the most affected country with~ 83.1% of the cases and~ 38.8% local …

Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies

J Choi, JO Kim - Journal of Microbiology, 2022 - Springer
Abstract Middle East Respiratory Syndrome coronavirus (MERS-CoV), a contagious
zoonotic virus, causes severe respiratory infection with a case fatality rate of approximately …

Anti-S1 MERS-COV IgY specific antibodies decreases lung inflammation and viral antigen positive cells in the human transgenic mouse model

AT Abbas, SA El-Kafrawy, SS Sohrab, AA Tabll… - Vaccines, 2020 - mdpi.com
The Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in 2012 and
causes severe and often fatal acute respiratory illness in humans. No approved prophylactic …

Middle East respiratory syndrome coronavirus: five years later

AA Rabaan - Expert Review of Respiratory Medicine, 2017 - Taylor & Francis
Introduction: In the past five years, there have been 1,936 laboratory-confirmed cases of
Middle East Respiratory Syndrome coronavirus (MERS-CoV) in 27 countries, with a mortality …